Сіз Bookimed қызметтері үшін төлемейсіз. увеиттің емдеудің бағалары клиниканың баға тізіміне сәйкес келеді. Сіз жеткенде тікелей клиникада төлейсіз. Бөліктермен төлеу қолжетімді.
Bookimed Сіздің қауіпсіздігіңізді қамтамасыз етеді. Біз тек увеиттің жүргізу үшін жоғары халықаралық стандарттарға сәйкес келетін клиникалармен ғана жұмыс істейміз. Олардың бүкіл әлем бойынша халықаралық науқастарға қызмет көрсету үшін қажетті лицензиялары бар.
Bookimed тегін көмек және қолдау ұсынады. Жеке медициналық координатор сапарға дейін, кезінде және кейін Сізбен байланыста. увеиттің емдеу кезінде Сіз басқа елде жалғыз қалмайсыз.
Dr. Jinchul Kim is the Director and Ophthalmologist at Samsung Miracle Eye Clinic in Gangnam, Seoul. He specializes in refractive surgery, including SMILE and laser procedures, and in cataract and IOL surgery with custom lens planning. He earned his M.D. from Seoul National University College of Medicine. He completed specialist training in ophthalmology at Samsung Seoul Hospital and now serves as a Visiting Professor there. He also received advanced clinical training at the Mayo Clinic in the United States.
His achievements include the “Miracle Formula,” the world’s first IOL power calculation program tailored to Asian biometric profiles (patent pending). He holds ZEISS SMILE Excellent Surgeon certification. He has been invited to lecture at the IOL Power Club 2025 (first Korean invitee), ASCRS 2025, and ESCRS 2023. His professional memberships include KOS, AAO, APAO, ESCRS, ASCRS, APACRS, KEEDS, and KCLS.
Dr. Yoon-Jung Jo is a board-certified ophthalmologist and Director at Samsung Miracle Eye Clinic (Gangnam, Seoul). She earned her MD and completed an ophthalmology residency at Hallym University Medical Center. She later served as a visiting professor and clinical faculty member. She also served as Director of Cheonan Kim Eye Clinic.
She is a refractive surgery specialist. Her focus includes SMILE, LASIK, and 1:1 customized astigmatism and vision correction. Dr. Jo is a certified ZEISS SMILE Excellent Surgeon. She is an active member of KOS, AAO, APAO, KSCRS, ESCRS, ASCRS, ARVO, KEEDS, and KCLS.
Dr. Seong-Won Cho is Director of Ophthalmology and a refractive surgery specialist at Samsung Miracle Eye Clinic in Gangnam, Seoul. He is board-certified. He completed his internship and ophthalmology residency at Korea University Anam Hospital. He earned a bachelor’s degree from Boston University. He focuses on advanced vision correction, including SMILE and LASIK. He previously served as Director at Blue World Eye Clinic. He was also an outpatient ophthalmology consultant at Inha University Hospital.
Accreditations: ZEISS SMILE Excellent Surgeon (Certified). Memberships: Korean Medical Association; Korean Ophthalmological Association; Korean Ophthalmological Society; American Academy of Ophthalmology; Asia Pacific Association of Ophthalmologists; Korean External Eye Study Group; Korean Contact Lens Society; Korean Society of Cataract & Refractive Surgery; European Society of Cataract & Refractive Surgeons; American Society of Cataract & Refractive Surgery; ARVO.
South Korea provides advanced uveitis treatments including locally developed hydrogel drug delivery systems and biologic therapies like Adalimumab. Top Seoul institutions utilize rapid multiplex PCR testing and metagenomic deep sequencing for precise diagnosis. Patients access high-level tertiary care through board-certified specialists at major university hospitals and specialized centers.
Bookimed Expert Insight: Korea excels in diagnostic speed for complex eye inflammation. Board-certified specialists like Dr. Sungwon Cho and Dr. Jinchul Kim at high-volume Seoul centers often have training from top global institutions like the Mayo Clinic. This ensures that systemic workups to rule out autoimmune triggers happen much faster than in many Western systems.
Patient Consensus: Patients note it is critical to see a retina specialist early to avoid misdiagnosis. Many emphasize bringing complete medical records to speed up their specialist evaluation process.
Major university hospitals in Seoul provide advanced uveitis care by coordinating ophthalmology with rheumatology and immunology departments. Institutions like Samsung Medical Center and Seoul National University Hospital (SNUH) specialize in complex cases. They effectively manage underlying systemic causes such as autoimmune disorders or infectious diseases.
Bookimed Expert Insight: Samsung Miracle Eye Clinic serves as a specialized option for vision correction, led by doctors like Dr. Jinchul Kim who trained at the Mayo Clinic and Samsung Seoul Hospital. While university hospitals handle acute inflammation, clinics with international expertise provide highly customized 1:1 surgical planning for long-term vision restoration.
Patient Consensus: Patients emphasize finding a dedicated uveitis specialist because the condition often requires complex workups for Behçet's disease or ankylosing spondylitis. Many note that large university hospitals are worth the longer wait times when oral steroids or biologics are required.
Korean eye centers treat diverse uveitis types including Behçet disease, Vogt-Koyanagi-Harada syndrome, and psoriatic uveitis. Specialized ophthalmologists manage refractory noninfectious cases using advanced biologics. Clinics provide comprehensive diagnostics for infectious, autoimmune, and idiopathic origins to prevent vision loss from chronic inflammation.
Bookimed Expert Insight: Korean ophthalmology thrives on high-volume expertise, with specialists like Dr. Jinchul Kim bringing advanced clinical training from the Mayo Clinic to Seoul. Our data shows a pattern where top-tier directors often hold memberships in both American and European societies. This global integration ensures patients receive the latest biological therapies and customized care plans for complex vitreous haze.
Patient Consensus: Patients emphasize finding a dedicated subspecialist rather than a general eye doctor to avoid misdiagnosis. Many note that bringing complete medication histories helps speed up the intensive evaluation required for posterior uveitis.
Uveitis treatment in Korea involves specialized drug delivery tailored to inflammation severity. Board-certified ophthalmologists prioritize corticosteroids via topical drops, oral tablets, or local injections. Advanced clinics utilize protocol-driven therapy to manage ocular pressure and prevent vision loss during the inflammatory tapering process.
Bookimed Expert Insight: Korean ophthalmology centers distinguish themselves through high-efficiency, specialist-driven protocols. While many global clinics wait for drug responses, Korean doctors often employ local injections earlier if inflammation appears vision-threatening. Dr. Jinchul Kim at Samsung Miracle Eye Clinic, who trained at the Mayo Clinic, emphasizes 1:1 customized surgical and treatment planning. This approach ensures delivery methods match specific biometric profiles for better outcomes.
Patient Consensus: Patients note that care feels fast and results-oriented. Many emphasize the importance of frequent eye pressure checks, as Korean specialists adjust steroid tapering schedules quickly to avoid side effects.
South Korean researchers are developing inflammation-responsive drug delivery systems for uveitis. New hydrogels release medications based on internal inflammation levels. Other breakthroughs include adalimumab injections for refractory cases. Local specialists also investigate blocking the PROX1 protein to trigger long-term retinal cell regeneration.
Bookimed Expert Insight: While South Korea ranks 7th globally for medical requests, its true strength lies in academic expertise. Dr. Jinchul Kim at Samsung Miracle Eye Clinic even developed a specialized formula for Asian ocular biometric profiles. This level of localization ensures that experimental therapies like adalimumab are dosed precisely for regional patient needs.
Patient Consensus: Patients note that reaching a specialist quickly is more vital than finding a miracle drug. They prioritize centers that can rapidly evaluate underlying causes and switch to biologics when standard steroids fail.
Uveitis can be permanently cured if an underlying infection is identified and eliminated. However, cases linked to autoimmune disorders are typically managed as chronic conditions. Success relies on early diagnosis by board-certified ophthalmologists to control inflammation and prevent permanent vision loss.
Bookimed Expert Insight: South Korea ranks 7th globally in our network for patient requests. Top clinicians like Dr. Jinchul Kim integrate advanced clinical training from the Mayo Clinic. This high-level expertise is vital because vision damage can occur even when inflammation seems controlled. Choosing a specialist with international training ensures access to the latest global protocols for chronic eye inflammation.
Patient Consensus: Patients note that recurring flares are often a surprise and emphasize the need for consistent follow-up care. Many find that while a permanent cure is elusive, maintaining a strict treatment schedule allows for long periods of manageable remission.